J.W.D. de Waard
J.W.D. de Waard publishes mostly in Surgery, Oncology and Pathology and Forensic Medicine, on topics such as Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments and Genetic factors in colorectal cancer.
- World rank
- #3,547,180 of 7,710,434 ranked researchers
- Rank in Netherlands
- #70,036 of 107,149
- Works
- 22
- Citations
- 602
- Citations per work
- 27.4
What does J.W.D. de Waard research?
J.W.D. de Waard's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1776.3%
- Medicine1776.3%
- Everything else418.9%
- Life Sciences14.8%
- 1Surgery30% of their works
- 2Oncology22% of their works
- 3Pathology and Forensic Medicine14% of their works
- 4Pulmonary and Respiratory Medicine5% of their works
- 5Epidemiology5% of their works
- 6Cancer Research5% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Genetic factors in colorectal cancer
- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
- Gastrointestinal Tumor Research and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Gastric Cancer Management and Outcomes
Which keywords describe J.W.D. de Waard's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Adjuvant Chemotherapy, Molecular Subtypes, Chemotherapy, Neoadjuvant Therapy, Cetuximab, KRAS Mutations and Molecular Characterization.
- Liver Cancer
- Hepatocellular Carcinoma
- Endoscopic Resection
- Gene Expression
- Breast Cancer
- Microsatellite Instability
- Rectal Cancer
- Molecular Characterization
- Cetuximab
- Chemotherapy
- Adjuvant Chemotherapy
- Clinical Practice Guidelines
- Molecular Subtypes
- Neoadjuvant Therapy
- KRAS Mutations
- Preoperative Chemoradiotherapy
- Hereditary Syndromes
- Survival Analysis
- Breast Tumours
- Mammography
- Gastric Cancer
- Imatinib Mesylate
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Clinical Practice Guidelines134 topics
- Adjuvant Chemotherapy112 topics
- Molecular Subtypes102 topics
- Chemotherapy92 topics
- Neoadjuvant Therapy92 topics
- Cetuximab71 topic
- KRAS Mutations71 topic
- Molecular Characterization72 topics
- Preoperative Chemoradiotherapy61 topic
- Rectal Cancer61 topic
- Hereditary Syndromes51 topic
- Microsatellite Instability51 topic
- Survival Analysis52 topics
- Breast Cancer31 topic
- Breast Tumours31 topic
- Gene Expression31 topic
- Mammography31 topic
- Endoscopic Resection21 topic
- Gastric Cancer21 topic
- Hepatocellular Carcinoma21 topic
- Imatinib Mesylate21 topic
- Liver Cancer21 topic
- Sunitinib21 topic
Where does J.W.D. de Waard work?
J.W.D. de Waard's main affiliation in the publication record is Westfriesgasthuis, Netherlands.
How many publications and citations does J.W.D. de Waard have?
OpenAlex counts 22 works and 602 citations for J.W.D. de Waard, an h-index of 12, ranking #3,547,180 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about J.W.D. de Waard. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.